Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5802/crbiol.36 http://scihub22266oqcxt.onion/10.5802/crbiol.36 34213846!ä!34213846 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       C+R+Biol 2021 ; 344 (1): 19-25 Nephropedia Template TP {{tp|p=34213846|t=2021. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia |pdf=|usr=}}{{34213846}} gab.com Text Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia JO: C R Biol http://www.kidney.de/pget.php?&tw=1&pmid=34213846 #FOAvip We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at least 10% of patients with life-threatening COVID-19 pneumonia had neutralizing auto-Abs against some of the 17 individual type I IFNs. These findings indicate that impaired type I IFN immunity underlies life-threatening COVID-19 pneumonia in at least 13% of patients. These discoveries pave the way for further research into unexplained severe cases, and provide a rationale for preventing and treating the disease in individuals at risk, with recombinant type I IFNs. Twit Text FOAVip Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia ????C R Biol http://www.kidney.de/pget.php?&tw=1&pmid=34213846 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34213846 #FOAvip English Wikipedia <ref>{{Cite pmid|34213846}}</ref> Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia #MMPMID34213846 Bastard P; Zhang Q; Cobat A; Jouanguy E; Zhang SY; Abel L; Casanova JL C R Biol 2021[Jun]; 344 (1): 19-25 PMID34213846show ga We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at least 10% of patients with life-threatening COVID-19 pneumonia had neutralizing auto-Abs against some of the 17 individual type I IFNs. These findings indicate that impaired type I IFN immunity underlies life-threatening COVID-19 pneumonia in at least 13% of patients. These discoveries pave the way for further research into unexplained severe cases, and provide a rationale for preventing and treating the disease in individuals at risk, with recombinant type I IFNs. |*COVID-19[MESH] |*Interferon Type I[MESH] |*Pneumonia[MESH] |Humans[MESH]Insufficient type I IFN immunity underlies life-threatening COVID-19 p(epmc).pdf DeepDyve Pubget Overpricing